EUVIMEDEUVIMED entdecken
Crossref

Age-related alterations in plasma biomarkers of relevance to Alzheimer's disease are attenuated in KLOTHO KL-VS heterozygotes

Ira Driscoll iD, Rachael E Wilson, Sterling C Johnson, Sanjay Asthana, Catherine L Gallagher, Bruce P Hermann, Mark A Sager, Cynthia M Carlsson, Kaj Blennow iD, Henrik Zetterberg, Dena B Dubal, Ozioma C Okonkwo

Journal of Alzheimer’s Disease · 2026-04 · 110 (3) · 1175-1182

DOI: 10.1177/13872877261422411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 06.03.2026. Verfasst von Ira Driscoll und 11 weiteren Autor:innen. Beteiligte Einrichtung: Wisconsin Alzheimer's Disease Research Center, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Glucuronidase, Aging. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Center for Advancing Translational Sciences, National Institute of Neurological Disorders and Stroke, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The literature supports an attenuation of unfavorable age-related changes, in both cognitive performance and CSF biomarkers of significance to Alzheimer's disease (AD), in association with a functionally advantageous KLOTHO KL-VS genotype (KL-VS HET ).

Objective

To examine whether KL-VS HET attenuation of unfavorable age-related biomolecular changes is detectable in AD-relevant plasma biomarkers.

Methods

Sample consisted of 298 cognitively unimpaired adults (Mean AGE = 65 ± 6.8, 67% female) from the Wisconsin Registry for Alzheimer's Prevention and the Wisconsin Alzheimer's Disease Research Center studies with available data of interest. Covariate (sex, education, APOE 4+/- status, parental history of AD)-adjusted multivariate regression examined relationships between age group (Younger (N = 140), Older (N = 158); mean split at age 65) and AD-relevant plasma biomarkers [amyloid-β (Aβ) 42/40, phosphorylated tau (pTau)181, pTau217, pTau231, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP)] and whether these relationships differ for KL-VS HET [N = 86; Younger = 51 (59%), Older = 35 (41%)] compared to non-carriers [KL-VS NC : N = 212; Younger = 89 (42%), Older = 123 (58%)].

Results

In the pooled sample, older age was associated with less favorable plasma biomarker profiles (all ps ≤ 0.001), except Aβ 42 (p = 0.39). When the analyses were stratified by genotype, KL-VS NC continued to exhibit the same age-related pattern of changes in plasma biomarkers (all ps ≤ 0.009; except Aβ 42 , p = 0.63), which was attenuated in KL-VS HET for Aβ 40 , Aβ 40/42 , pTau181, pTau217, and pTau231 (all ps ≥ 0.1).

Conclusions

Unfavorable age-associated changes in core AD plasma biomarkers were attenuated in KLOTHO KL-VS HET . KL-VS HET seems to be protective against age-related biomolecular alterations known to confer risk for developing AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGlucuronidaseAgingHumansFemaleKlotho ProteinsBiomarkersAmyloid beta-Peptidestau ProteinsAgedMaleMiddle AgedHeterozygotePeptide FragmentsNeurofilament ProteinsGlial Fibrillary Acidic ProteinGenotype

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkerscognitively unimpairedplasmaresistance to ADrisk

Substanzen

Klotho ProteinsGlucuronidaseBiomarkersAmyloid beta-Peptidestau ProteinsKL protein, humanamyloid beta-protein (1-42)Peptide FragmentsNeurofilament ProteinsGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • Wisconsin Alzheimer's Disease Research Center, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Wisconsin Alzheimer's Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Geriatric Research Education and Clinical Center, William S. Middleton VA Hospital, Madison, WI, USA.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.

ORCID-Profile: Ira Driscoll, Kaj Blennow

Förderung

  • National Center for Advancing Translational Sciences
  • National Institute of Neurological Disorders and Stroke
  • National Institute on Aging

Zitieren

APA

Driscoll, I., Wilson, R. E., Johnson, S. C., Asthana, S., Gallagher, C. L., Hermann, B. P., Sager, M. A., Carlsson, C. M., Blennow, K., Zetterberg, H., Dubal, D. B., & Okonkwo, O. C. (2026). Age-related alterations in plasma biomarkers of relevance to Alzheimer's disease are attenuated in KLOTHO KL-VS heterozygotes. Journal of Alzheimer’s Disease, 110(3), 1175-1182. https://doi.org/10.1177/13872877261422411

Vancouver

Driscoll I, Wilson RE, Johnson SC, Asthana S, Gallagher CL, Hermann BP, et al. Age-related alterations in plasma biomarkers of relevance to Alzheimer's disease are attenuated in KLOTHO KL-VS heterozygotes. Journal of Alzheimer’s Disease. 2026;110(3):1175-1182. doi:10.1177/13872877261422411

BibTeX
@article{Driscoll2026,
  author = {Driscoll, Ira and Wilson, Rachael E and Johnson, Sterling C and Asthana, Sanjay and Gallagher, Catherine L and Hermann, Bruce P and Sager, Mark A and Carlsson, Cynthia M and Blennow, Kaj and Zetterberg, Henrik and Dubal, Dena B and Okonkwo, Ozioma C},
  title = {Age-related alterations in plasma biomarkers of relevance to Alzheimer's disease are attenuated in KLOTHO KL-VS heterozygotes},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  volume = {110},
  number = {3},
  pages = {1175--1182},
  doi = {10.1177/13872877261422411}
}
Kostenlos starten →